Trifluoroacetic acid → HCID 131723147, compound
Reaction equation
[CH3:1][S:2]([C:5]1[CH:31]=[CH:30][C:8]([CH2:9][N:10]2[CH:14]=[C:13]([CH:15]3[CH2:20][CH2:19][N:18](C(OC(C)(C)C)=O)[CH2:17][CH2:16]3)[C:12]([CH2:28][CH3:29])=[N:11]2)=[CH:7][CH:6]=1)(=[O:4])=[O:3].[C:32]([OH:38])([C:34]([F:37])([F:36])[F:35])=[O:33]>>[OH:38][C:32]([C:34]([F:37])([F:36])[F:35])=[O:33].[OH:38][C:32]([C:34]([F:37])([F:36])[F:35])=[O:33].[CH3:1][S:2]([C:5]1[CH:6]=[CH:7][C:8]([CH2:9][N:10]2[CH:14]=[C:13]([CH:15]3[CH2:20][CH2:19][NH:18][CH2:17][CH2:16]3)[C:12]([CH2:28][CH3:29])=[N:11]2)=[CH:30][CH:31]=1)(=[O:3])=[O:4]Participants
3
Procedure
4-((1-(4-Methylsulfonylbenzyl)-3-ethyl)-(1H)-pyrazol-4-yl)-N-t-butoxylcarbonylpiperidine from Step C was treated with TFA for 1 h and evaporated to afford the title compound as the TFA salt.
Workup
- customevaporated
Sources & evidence
- ORD record
- ord-54fe4a91cb9348c3abcb05cb2ff83d91
- Source dataset
- uspto-grants-2003_07
- Patent number
- US06593346B2
Reaction notes
Loading…